Cox Regression Analysis: All Patients
| . | OS . | EFS . |
|---|---|---|
| . | P . | P . |
| All variables | ||
| Duration of remission | NS | <.01 |
| B symptoms at relapse | .04 | NS |
| Response to cytoreductive therapy | <.01 | <.01 |
| Treatment at relapse (HDT v CS) | NS | <.01 |
| Excluding response | ||
| Duration of remission | NS | <.01 |
| Prior radiotherapy | NS | .02 |
| B symptoms at relapse | <.01 | <.01 |
| Treatment at relapse (HDT v CS) | .04 | <.01 |
| . | OS . | EFS . |
|---|---|---|
| . | P . | P . |
| All variables | ||
| Duration of remission | NS | <.01 |
| B symptoms at relapse | .04 | NS |
| Response to cytoreductive therapy | <.01 | <.01 |
| Treatment at relapse (HDT v CS) | NS | <.01 |
| Excluding response | ||
| Duration of remission | NS | <.01 |
| Prior radiotherapy | NS | .02 |
| B symptoms at relapse | <.01 | <.01 |
| Treatment at relapse (HDT v CS) | .04 | <.01 |
Other variables entered into the analysis include: stage at initial diagnosis, B symptoms at initial diagnosis, stage at relapse, number of extra nodal disease sites at relapse, prior radiotherapy, relapse in site of prior radiotherapy. NS: P > .20.